![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Eko Earns Breakthrough Designation for Heart Failure Screening Algorithm
Eko Earns Breakthrough Designation for Heart Failure Screening Algorithm
![heart-on-yellow.gif](https://www.fdanews.com/ext/resources/test/Device_Images/heart-on-yellow.gif?t=1577068037&width=430)
December 20, 2019
The FDA has granted breakthrough designation status for Eko’s ECG-based algorithm designed to improve screening for heart failure.
During a physical exam, the algorithm analyzes 15 seconds of ECG data collected by an Eko DUO digital stethoscope to help identify left ventricular ejection failure, a measurement used in the diagnosis of heart failure.
The technology gives physicians the capability to detect heart disease in patients before it develops into a more serious condition.
Upcoming Events
-
21Oct